OTC : BBBT
$0 (0.0%)
Industry, Sector & symbol
| Stock Exchange | OTC |
| CEO | Nelson Grist |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Current Symbol | BBBT |
| CUSIP | 09183V101 |
| CIK | 0001409999 |
| Web | https://blackbirdbiotech.com |
| Phone | 833 223 4202 |
| Currency | USD |
| Employees | 4 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | -1.03 |
| Payout Ratio | 0.00 |
| Current Ratio | 0.16 |
| Quick Ratio | 0.05 |
| Cash Ratio | 0.05 |
Sales & Book Value
| Annual Sales | $82563 |
| Price / Sales | 1.19 |
| Cash Flow | 0.00 |
| Price / Cash Flow | -0.10 |
| Price / Book | -0.05 |
Price Target and Rating
| Average Stock Price Forecast | |
| High Stock Price Forecast | |
| Low Stock Price Forecast | |
| Forecast Upside/Downside | % |
| Consensus Rating | N/A |
| Rating Score(0-5) | 0 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | -$0.005 |
| Trailing P/E Ratio | -0.02 |
| PEG Ratio | 0.00 |
| P/E Growth | 0.00 |
| Net Income | -$1.66M |
| Net Margin | -2009.09% |
| Pretax Margin | -2009.09% |
| Return on Equity | -16554.55% |
| Return on Assets | -759.13% |
Financials Score
| AltmanZ Score | -90.43 |
| Piotroski Score | 1.00 |
| Working Capital | -927.55K |
| Total Assets | 98.78K |
| Ebit | -314.15K |
| Market Cap | 98.4K |
| Total Liabilities | 1.02M |
About Black Bird Biotech, Inc. (OTC:BBBT) Stock
Black Bird Biotech Inc. operates within the biotechnology sector, offering a diverse array of products. A key offering is MiteXstream, a unique plant-derived biopesticide manufactured and distributed by the company, specifically formulated to eradicate spider mites. The company further diversifies its portfolio with a range of consumer goods sold under its Grizzly Creek Naturals brand. These include CBD oils, gummies, and pet treats, as well as CBD-infused personal care items and both gel and spray hand sanitizer products. Beyond these offerings, Black Bird Biotech also engages in the cultivation of industrial hemp, participating in the Montana Hemp pilot program. The entity, headquartered in Flower Mound, Texas, underwent a name change in June 2021, transitioning from its former identity ... as Digital Development Partners, Inc. to its current Black Bird Biotech, Inc. designation.
Frequently Asked Questions
What is the current Black Bird Biotech, Inc. (BBBT) stock price?
Black Bird Biotech, Inc.(OTC:BBBT) stock price is $0.0001 in the last trading session. During the trading session, BBBT stock reached the peak price of $0.0001 while $0.0001 was the lowest point it dropped to. The percentage change in BBBT stock occurred in the recent session was 0.0% while the dollar amount for the price change in BBBT stock was $0.
BBBT's industry and sector of operation?
The OTC listed BBBT is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
Who are the executives of BBBT?
William E. Sluss
| Chief Financial Officer, Vice President of Finance & Director
Eric Newlan
| Vice President, Secretary & Director
Fabian G. Deneault
| Chairman of the Board & President
Nelson Grist
| Chief Executive Officer
William J. LoBell
| Executive Vice President of Sales & Development
How many employees does BBBT have?
Number of BBBT employees currently stands at 4. BBBT operates from 3505 Yucca Drive, Argyle, TX 75028, US.
Link for BBBT official website?
Official Website of BBBT is: https://blackbirdbiotech.com
How do I contact BBBT?
BBBT could be contacted at phone #833 223 4202 and can also be accessed through its website. BBBT operates from 3505 Yucca Drive, Argyle, TX 75028, US.
How many shares of BBBT are traded daily?
The average number of BBBT shares traded daily for last 3 months was 1.82M.
What is the market cap of BBBT currently?
The market value of BBBT currently stands at $98.4K with its latest stock price at $0.0001